JBS stock faces November 9 earnings after a Q2 miss

Published on 10/07/2026 at 00:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JBS generated USD 23.90 billion in Q2 2026 revenue, 3.7 percent above estimates. Analysts put the average 12-month target at USD 17.88, with a Buy consensus.

JBS, BRJBSSACNOR8, Illustration mit AI erstellt.

JBS stock (ISIN BRJBSSACNOR8) was last at USD 12.02 on the NYSE on October 6, 2026 at 4:00 p.m. ET, up 1.09 percent from the prior close. The next earnings report is scheduled for November 9, 2026, according to AlgovestIQ, putting the recent quarterly miss back at the center of the stock story.

Q2 revenue beat, earnings missed

Gekko reports that JBS generated USD 23.90 billion in Q2 2026 revenue, 3.7 percent above the USD 23.04 billion estimate. Adjusted EPS came in at USD 0.20 against a USD 0.31 consensus estimate, a 35.0 percent shortfall.

The operating mix was uneven rather than uniformly weak. Q2 adjusted EBITDA reached USD 1.43 billion under IFRS and adjusted net income was USD 218 million, while Brazil beef delivered record adjusted EBITDA of USD 269 million, according to Gekko.

November report sets next test

The November 9, 2026 report is the next dated checkpoint for the business, with analysts expecting USD 0.34 in EPS and USD 23.63 billion in revenue, according to AlgovestIQ. The revenue estimate is below the USD 23.90 billion achieved in Q2 2026, making margin conversion and earnings quality more important than headline sales growth.

The same consensus carries a Buy label across 14 ratings, including 12 Buy and 2 Hold recommendations. Its USD 17.88 average target is 48.8 percent above the USD 12.02 reference price, while the published target range runs from USD 17.00 to USD 20.00.

Leather deal adds operating angle

JBS is also reshaping its leather operations. In a September 15, 2026 filing, the SEC filing said JBS S.A. agreed to combine relevant assets with Viva Holding in JBS Viva, with each party set to own 50 percent. Completion depends on customary conditions, and the structure includes supply arrangements linking raw hides with materials for JBS gelatin and collagen products.

The transaction creates a shared leather platform while leaving several assets outside its scope, including collagen and gelatin activities and selected operations in Texas, Germany, Uruguay and Mexico. For investors, the strategic logic is visible in the operating link, but the November earnings report remains the clearer test of whether revenue growth is translating into profit.

JBS stock stays below yearly high

JBS stock was last at USD 12.02 on the NYSE on October 6, 2026 at 4:00 p.m. ET, with volume of 4,803,778 shares and a market capitalization of USD 26.7 billion. The price stood 35.5 percent below the 52-week high of USD 18.65 and above the 52-week low of USD 10.61.